131 results on '"Mobile tongue"'
Search Results
2. Combined loss of expression of involucrin and cytokeratin 13 is associated with poor prognosis in squamous cell carcinoma of mobile tongue.
- Author
-
Pandey, Sushma, Søland, Tine Merete, Bjerkli, Inger Heidi, Sand, Lars Peter, Petersen, Fernanda Cristina, Costea, Daniela Elena, Senguven, Burcu, and Sapkota, Dipak
- Subjects
SQUAMOUS cell carcinoma ,TONGUE cancer ,KERATIN ,PROGNOSIS ,OVERALL survival ,TRANSCRIPTOMES - Abstract
Background: This study aimed to evaluate the prognostic significance of expression levels of involucrin (IVL), cytokeratin (CK)‐10 and ‐13 at different intratumor sites (tumor center and invading area) of oral tongue squamous cell carcinoma (OTSCC). Methods: IVL, CK13 and CK10 expression levels were examined in a multicenter cohort of 146 OTSCCs using immunohistochemistry. External mRNA datasets were used for expression analysis and/or to validate survival associations. Results: External transcriptomic datasets showed downregulation of IVL and KRT13 in oral malignancies including OTSCC as compared to normal controls. The combined loss of IVL and CK13 expression at the invading core but not at the center core was significantly associated with poor differentiation and reduced 5‐year overall survival. Multivariate Cox analysis confirmed the loss of CK13 and IVL expression to be an independent prognostic factor. Transcriptomic dataset corroborated immunohistochemistry results. Conclusions: Combined expression levlels of IVL and CK13 might be useful as prognostic biomarkers in OTSCC. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
3. Keratin 36, a specific marker of tongue filiform papillae, is downregulated in squamous cell carcinoma of the mobile tongue.
- Author
-
Brychtova, Veronika, Coates, Philip J., Hrabal, Vaclav, Boldrup, Linda, Fabian, Pavel, Vojtesek, Borivoj, Sgaramella, Nicola, and Nylander, Karin
- Subjects
- *
SQUAMOUS cell carcinoma , *KERATIN , *BASAL cell carcinoma , *TONGUE cancer , *CERVICAL cancer - Abstract
Human keratin 36 (K36) is a member of the hair keratin family and is a marker of hair cortex differentiation. The human KRT36 gene is located on the long arm of chromosome 17 and belongs to the cluster of structurally unrelated acidic hair keratins. Recently, it has been reported that KRT36 mRNA is specifically expressed in normal tongue epithelium and downregulated in squamous cell carcinomas of the mobile tongue. Furthermore, KRT36 levels have been reported to be downregulated in clinically normal mobile tongue tissue that is adjacent to tumours, suggesting it could be a marker of pre-neoplastic changes. However, the exact role and the potential role of K36 in tongue tumour formation remains unclear. The aim of the present study was to investigate expression of K36 in a series of squamous cell carcinomas of the mobile tongue, normal mobile tongue and a small panel of other human tissues (normal tissue from the appendix, cervix, hair, lip, mamilla, nail, oesophagus, skin, thymus and vagina) and selected cancer tissue (cervical cancer, melanoma and basal cell carcinoma). Affinity purified polyclonal antibodies against K36 were generated and used for immunohistochemical analysis. The results revealed that in the normal tongue, K36 was detected specifically in the filiform papillae of the dorsal surface of the tongue. Additionally, none of the tongue cancer tissue samples were K36-positive. Immunostaining also revealed that K36 was expressed in nail beds, Hassal's corpuscles in the thymus and the hair cortex. However, K36 was not expressed in the squamous epithelia of the skin, cervix and oesophagus, and the squamous cells of cervical carcinomas, basal cell carcinoma or melanoma. The present data indicated that K36 may be inactivated in tumours of the tongue. However, whether this is part of the tumoural process or if it is an effect of the tumour itself remains to be elucidated. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
4. A rapidly growing human papillomavirus-positive oral tongue squamous cell carcinoma in a 21-year old female: A case report.
- Author
-
Appah, Ebenezer O., Ballard, Billy Ray, Izban, Michael G., Jolin, Cassandra, Lammers, Philip E., Parrish Jr, Dwight D., and Marshall, Dana R.
- Subjects
- *
TONGUE cancer , *SQUAMOUS cell carcinoma , *PAPILLOMAVIRUS diseases , *POLYMERASE chain reaction , *GENETIC mutation - Abstract
Oral tongue squamous cell carcinoma (OTSCC) has a median age at diagnosis of 62 years. The incidence of OTSCC in young adults has been increasing, and the reason is unclear. The present study describes a case, and molecular analysis, of OTSCC in a 21-year-old female. Clinical and pathological information were collected from medical records. Formalin-fixed paraffin-embedded biopsy tissue from the patient was reassessed using standard hematoxylin & eosin staining, and immunohistochemistry was used to assess the expression of cellular p16, MutL homolog (MLH)1, MLH2, MutS homolog 6 (MSH6) and PMS1 homolog 2 (PMS2). The human papilloma virus (HPV) genome was detected by PCR analysis of the extracted DNA. The young age of the patient with OTSCC was unusual. The original pathology report indicated koilocytotic atypia, a cellular abnormality associated with HPV. Although HPV-positive oral cancer tends to occur in 'younger' individuals, 21 years is unusual. The confirmation of biologically active HPV in the tumor was obtained via the observation of strong positive staining for cellular p16. The patient described a maternal family cluster of rare cancer types, thus the possibility that this rapidly growing cancer resulted from HPV infection combined with an underlying genetic mutation causing decreased DNA-mismatch repair was explored. However, MSH1, MSH2, MSH6 and PSM2, proteins that are associated with Lynch Syndrome, were expressed at normal levels. A rapidly growing OTSCC of a 21-year-old female was determined to be HPV-positive. The patient underwent combination chemotherapy and radiation and has experienced long-term survival without recurrence. The reason this tumor grew so quickly in such a young individual remains unknown. These types of cases warrant additional genomic and proteomic studies to improve understanding of this phenomenon. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
5. Update from the 4th Edition of the World Health Organization of Head and Neck Tumours: Tumours of the Oral Cavity and Mobile Tongue.
- Author
-
Müller, Susan
- Abstract
There have been several additions and deletions in Chapter 4 on Tumours of the oral cavity and mobile tongue in the 2017 fourth edition of the World Health Organization Classification of Tumours of the Head and Neck. This chapter excludes the oropharynx, which now is a stand-alone chapter acknowledging the uniqueness of the oropharynx from the oral cavity. New entries in Chapter 4 include rhabdomyoma, haemangioma, schwannoma, neurofibroma and myofibroblastic sarcoma in the section titled Soft tissue and neural tumours. Discussion of salivary gland entities have been reduced and includes mucoepidermoid carcinoma and pleomorphic adenoma as the other salivary gland types are discussed elsewhere. In the Haematolymphoid tumours section, like the salivary gland section, only tumors that commonly present in the oral cavity are discussed in Chapter 4. Excluded entities in the updated classification include papillary hyperplasia, median rhomboid glossitis, keratoacanthoma, focal oral mucinosis, and secondary tumors. This article will summarize the changes in the new classification since the 2005 edition focusing on selected entities that have had significant changes along with new entries. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. The French Multicenter Trial: Results and Conclusions
- Author
-
Marchal, C., Prevost, B., Ardiet, J.-M., Gerard, J.-P., Cosset, J.-M., Seegenschmiedt, M. Heinrich, editor, and Sauer, Rolf, editor
- Published
- 1993
- Full Text
- View/download PDF
7. Interstitial Thermoradiotherapy for Head and Neck Tumors: Results of a Cooperative Phase 1–2 Study
- Author
-
Seegenschmiedt, M. H., Sauer, R., Fietkau, R., Iro, H., Brady, L. W., Seegenschmiedt, M. Heinrich, editor, and Sauer, Rolf, editor
- Published
- 1993
- Full Text
- View/download PDF
8. Rationale for Interstitial Thermoradiotherapy for Tumors in the Head and Neck Region
- Author
-
Fietkau, R., Grabenbauer, G. G., Seegenschmiedt, M. H., Seegenschmiedt, M. Heinrich, editor, and Sauer, Rolf, editor
- Published
- 1993
- Full Text
- View/download PDF
9. Cancers de la cavité buccale chez les sujets jeunes : résultats thérapeutiques et analyse de facteurs pronostiques.
- Author
-
Blanchard, P., El Khoury, C., Temam, S., Casiraghi, O., Mirghani, H., Lévy, A., Gorphe, P., Éven, C., De Felice, F., Nguyen, F., Janot, F., and Tao, Y.
- Abstract
Résumé Objectifs de l’étude Les carcinomes épidermoïdes de la cavité buccale du sujet jeune constituent une entité spécifique dont la prise en charge et le pronostic sont discutés. Nous avons effectué une analyse rétrospective des dossiers de l’ensemble des patients âgés de moins de 40 ans et pris en charge à Gustave-Roussy pour un carcinome épidermoïde de la cavité buccale entre 1999 et 2011. Méthodes Les caractéristiques des patients, des tumeurs, du traitement, et le devenir ont été enregistrés. Une analyse de survie par la méthode de Kaplan-Meier a été réalisée, ainsi qu’une analyse unifactorielle et multifactorielle à la recherche de facteurs pronostiques de la survie globale et la survie sans progression. Résultats Soixante-trois patients ont été identifiés. Le suivi médian était de 64 mois. La majorité des tumeurs siégeait au niveau de la langue mobile ( n = 54, 86 %). Au total 17 patients sont décédés, dont 15 du cancer traité. Les taux de survie globale et sans progression à 5 ans étaient de 80 % et 69 %. Les taux de survie sans rechute locale, régionale ou métastatique à 5 ans étaient de 80 %, 91 % et 89 %. En analyse multifactorielle, seule l’absence de chirurgie initiale était pronostique pour la survie globale ( hazard ratio [HR] : 13,5 [2,0 ; 90,5], p = 0,007), tandis que la consommation d’alcool (HR : 0,38 [0,15 ; 0,9], p = 0,03) et l’absence de chirurgie (HR : 9,8 [1,9 ; 50,9], p = 0,006) étaient associées à une diminution de la probabilité de survie sans progression. Un âge plus jeune (moins de 30 ans) n’était pas associé ni à la survie globale ni à celle sans progression. Conclusion Les taux de survie et de contrôle tumoral sont relativement élevés chez les sujets jeunes atteints de carcinome épidermoïde de la cavité buccale traités dans un centre tertiaire. L’identification préthérapeutique des sujets à risque de récidive est actuellement difficile. La balance entre risque de rechute et toxicité des traitements justifie la réalisation d’études supplémentaires, sur le plan clinique et pour le développement de biomarqueurs pronostiques. Purpose Squamous cell carcinomas of the oral cavity occurring in young people represent a specific entity. Its management and prognosis are controversial. We performed a retrospective chart review of all patients aged less than 40 years old and treated at Gustave-Roussy Cancer Centre for a squamous cell carcinomas of the oral cavity between 1999 and 2011. Methods Patients and tumour characteristics, type of treatment and follow-up data were collected. Survival data were analysed according to the methods of Kaplan-Meier and both univariate and multivariate analyses were performed to look for prognostic factors regarding overall survival and progression-free survival. Results Sixty-three patients were identified. Median follow-up was 64 months. Most of the tumours were initially located in the mobile tongue ( n = 54, 85.7%). Overall 17 patients had died, including 15 from the treated cancer. Overall and progression-free survival rates at 5 years were respectively 79.6% and 68.6%. The corresponding 5 years local, regional and metastatic relapse free survival rates were 80%, 91% and 89% respectively. In the multivariate analysis only the absence of initial surgery (hazard ratio [HR]: 13.5 [2.0; 90.5]; P = 0.007) was prognostic for overall survival, while alcohol abuse (HR: 0.37 [0.15; 0.9]; P = 0.03) and the absence of surgery (HR: 13.6 [2.5; 74.2]; P = 0.002) were associated with a decreased progression-free survival. A younger age (less than 30 year old) was not associated with the risk of recurrence or death. Conclusion Survival rates and tumour control probabilities are relatively high among young patients suffering from squamous cell carcinomas of the oral cavity treated at a tertiary centre. The early identification of patients at risk of relapse is currently difficult. The balance between recurrence and treatment toxicity warrants further studies, both on the clinical level and for the development of prognostic biomarkers. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
10. 198Au Implantation of Carcinoma of the Mobile Tongue
- Author
-
Slanina, Joachim, Kuphal, Klaus, Wannenmacher, Michael, and Sauer, Rolf, editor
- Published
- 1991
- Full Text
- View/download PDF
11. A new implant device to prevent edema-associated underdosage in high-dose-rate interstitial brachytherapy of mobile tongue cancer
- Author
-
Hideya Yamazaki, T. Shimbo, Mio Nakata, Yasuo Uesugi, Yutaka Tsujimoto, Nikolaos Tselis, Ken Yoshida, Hiroto Yoshioka, Tadayuki Kotsuma, Hironori Akiyama, Koji Masui, Tadashi Takenaka, Takumi Arika, Eiichi Tanaka, N. Yoshikawa, Yuji Takaoka, and Naoya Murakami
- Subjects
silicone device ,medicine.medical_treatment ,Brachytherapy ,lcsh:Medicine ,Case Report ,tongue edema ,chemistry.chemical_compound ,Silicone ,Tongue ,Edema ,medicine ,Dosimetry ,Radiology, Nuclear Medicine and imaging ,ddc:610 ,business.industry ,Interstitial brachytherapy ,lcsh:R ,Cancer ,medicine.disease ,medicine.anatomical_structure ,Oncology ,chemistry ,mobile tongue cancer ,medicine.symptom ,high-dose-rate interstitial brachytherapy ,Nuclear medicine ,business ,Mobile tongue - Abstract
Purpose: Tongue edema is a potential cause of treatment target underdosage in high-dose-rate interstitial brachytherapy (HDR-ISBT) of mobile tongue cancer. To prevent such edema-associated alteration of dosimetry, we developed a special silicon device. In this report we communicate our initial experience with two mobile tongue cancer patients whom we treated using this new device. Material and methods: The device consists of silicone tubes with a fixed width and scalable length depending on tongue size. These tubes are lined and fixed like a palisade, allowing the device to be used also as a template. The device is placed next to the lateral border of the tongue and on the floor of the mouth. In addition, a vinyl template can be placed on the dorsal tongue surface with both devices combined for implantation guidance. Between June and August 2012, two patients with locally confined tongue cancer were treated. Results: Between June and August 2012, two mobile tongue cancer patients classified as cT2N0M0 were treated with HDR-ISBT using the silicone device. They underwent ISBT as monotherapy with fractional doses of 6.0 Gy up to a total physical dose of 54.0 Gy. The D90 (CTV) values of both patients were 6.3 Gy and 6.6 Gy and the D2cc (mandible) values were 3.4 Gy and 2.6 Gy, respectively. At present, both patients remain without local disease recurrence at 60 and 56 months after ISBT, respectively. Conclusions: The described silicone device has the potential to prevent underdosage to the treatment target related to tongue edema. It has been shown to be safe and easy to implement.
- Published
- 2019
12. Long-term subjective tongue function after partial glossectomy.
- Author
-
Lee, D. Y., Ryu, Y.‐J., Hah, J. H., Kwon, T.‐K., Sung, M.‐W., and Kim, K. H.
- Subjects
- *
DEGLUTITION disorders , *TONGUE physiology , *ACADEMIC medical centers , *MULTIVARIATE analysis , *QUESTIONNAIRES , *SURGICAL complications , *DATA analysis software , *DESCRIPTIVE statistics , *DISEASE risk factors ,TONGUE surgery ,TONGUE tumors - Abstract
There have been limited studies of subjective tongue function over long-term follow-up in spite of swallowing and articulation disorders are common complications of glossectomy. To assess long-term subjective swallowing and articulation function after partial glossectomy. A total of 63 patients with the mobile tongue cancer who underwent partial glossectomy without reconstruction were interviewed to score their swallowing and articulation function on a 100-point scale. The relation of this subjective scoring to the perioperative data was subjected to multivariate analysis. The mean patient age was 53·4 (19-81) years, and the mean follow-up duration was 78·9 (14-277) months. Mean swallowing and articulation function score was 87·7 ± 6·1 and 88·6 ± 5·4. Age, follow-up duration, T stage and resection volume were significantly correlated with swallowing function ( P = 0·026, 0·029, 0·016, 0·002, respectively); follow-up duration was correlated with articulation function ( P = 0·039). Patients who undergo partial glossectomy without reconstruction generally demonstrate good function on long-term follow-up. Subjective dysfunction was correlated with larger resection volume, older age and shorter follow-up duration. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
13. Research on Mobile Tongue Diagnosis in Traditional Chinese Medicine
- Author
-
Kaiwen zheng, Jianjun Yan, Houru Chen, Kexin Mao, Weihong Pan, and Jinxing Cai
- Subjects
Multimedia ,business.industry ,Computer science ,Color correction ,Traditional Chinese medicine ,computer.software_genre ,Popularity ,medicine.anatomical_structure ,Feature (computer vision) ,Tongue ,medicine ,Segmentation ,The Internet ,business ,Mobile tongue ,computer - Abstract
With the development of the Internet and the popularity of the intelligent devices, the research on mobile tongue diagnosis in traditional Chinese medicine is deepening. This paper mainly introduces four relative critical technologies, namely acquisition, color correction, segmentation and feature processing of tongue images. At the same time, the research progress of relevant technologies in recent years is summarized to provide reference for further study on mobile tongue diagnosis platform of TCM(Traditional Chinese Medicine).
- Published
- 2020
- Full Text
- View/download PDF
14. Immunohistochemical analysis of BRCA1 and acetyl-histone H3 in squamous cell carcinoma of the mobile tongue
- Author
-
Thamiris de Castro Abrantes, P.V. Fernandes, Thamyres Campos Fonseca, B.A.B. de Andrade, Mário José Romañach, Aline Corrêa Abrahão, Michelle Agostini, and Márcia Grillo Cabral
- Subjects
Pathology ,medicine.medical_specialty ,Pathology and Forensic Medicine ,Histones ,03 medical and health sciences ,Histone H3 ,0302 clinical medicine ,Breast cancer ,Tongue ,medicine ,Biomarkers, Tumor ,Humans ,Radiology, Nuclear Medicine and imaging ,Dentistry (miscellaneous) ,Basal cell ,skin and connective tissue diseases ,Grading (tumors) ,business.industry ,BRCA1 Protein ,030206 dentistry ,medicine.disease ,Immunohistochemistry ,Well differentiated ,Tongue Neoplasms ,030220 oncology & carcinogenesis ,Carcinoma, Squamous Cell ,Surgery ,Oral Surgery ,Epidemiologic data ,business ,Mobile tongue - Abstract
The objective of this study was to evaluate the immunoexpression profiles of breast cancer 1 (BRCA1) and acetyl-histone H3 (AcH3) in squamous cell carcinoma of the mobile tongue (SCC-MT) and their correlation with epidemiologic data and the histopathological grade of tumors.Incisional biopsies of 43 SCC-MT were submitted to immunohistochemistry for AcH3 and BRCA1. Samples were microscopically graded as well differentiated (n = 21) or poorly differentiated (n = 22). Both groups were submitted to statistical analysis (P.05) regarding the percentage of positive cells.Thirty-nine cases were positive for AcH3 (91%), but no difference was observed for the histologic grading (P = .27). Positivity for BRCA1 was observed in all samples regardless of their cellular locations. Most cases in the poorly differentiated group presented with less than 10% nuclear staining (P.01) and a predominance of cytoplasmic staining (P = .034). The well-differentiated group showed nuclear staining in most of the cases, with more than 50% of cells staining positive (P.01).AcH3 and BRCA1 were expressed in all samples. There was a significant decrease in cytoplasmic BRCA1 expression in the poorly differentiated group, suggesting BRCA1 as a possible prognostic marker for SCC-MT.
- Published
- 2020
15. Autonomization of pectoralis major flap in head and neck surgery
- Author
-
G. Riva, M. Castelli, and Giancarlo Pecorari
- Subjects
Reconstructive surgery ,medicine.medical_specialty ,Free flap ,Free Tissue Flaps ,Pectoralis Muscles ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,030223 otorhinolaryngology ,Head and neck ,business.industry ,Head and neck cancer ,Pedicled Flap ,Plastic Surgery Procedures ,medicine.disease ,Surgery ,Pectoralis major flap ,Otorhinolaryngology ,Head and Neck Neoplasms ,030220 oncology & carcinogenesis ,Head and neck surgery ,Neoplasm Recurrence, Local ,business ,Mobile tongue - Abstract
The pectoralis major flap (PMF) is one of the most used pedicled flaps for reconstructive surgery in head and neck. Basing on previous studies observing that a vascular accident or pedicle ligation not always resulted in necrosis of free flaps, sometimes after a short critical period, we describe the possibility to perform the division of the PMF pedicle. The autonomization of PMF is based on the hypothesis that the flap, after a critical period, develops a neoangiogenesis at the free portion in the recipient site. It represents a possible choice in selected patients with relapse or second tumour of the oral floor and/or mobile tongue, who have been already treated with PMF reconstruction. We provide a step-by-step description of the autonomization and use of the modified PMF. Moreover, we reported advantages and pitfalls. The modified PMF represents a safe reconstructive choice for patients advised against a free flap or a second pedicled flap, with good surgical outcomes.
- Published
- 2020
16. Cancer of the Mobile Tongue: About 29 Cases Collected at the ENT and CCF Service of the University Hospital Centre of Fann (Dakar/Senegal)
- Author
-
Tall Abdourahmane, Niang Fallou, Dieye Abdoulaye, Ndiaye Ciré, Amelle Lokossou, Diallo Mamadou Diouldé, Ahmed Houra, Younes Hussen, Ndour Ngor, Ndiaye Issa Cheikh, and Ndiaye Malick
- Subjects
Service (business) ,medicine.medical_specialty ,business.industry ,General surgery ,medicine.medical_treatment ,Cancer ,University hospital ,medicine.disease ,Oral cavity ,Colloid and Surface Chemistry ,medicine.anatomical_structure ,Tongue ,Epidemiology ,medicine ,Glossectomy ,Physical and Theoretical Chemistry ,business ,Mobile tongue - Abstract
Cancers of the tongue are the most common cancers of the oral cavity with poor survival [1,2]. The main risk factors are...
- Published
- 2020
- Full Text
- View/download PDF
17. Peroxisome proliferator-activated receptor-γ in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
- Author
-
Theocharis, Stamatios, Klijanienko, Jerzy, Giaginis, Constantinos, Rodriguez, Jose, Jouffroy, Thomas, Girod, Angelique, Point, Daniel, Tsourouflis, Gerasimos, and Satre-Garau, Xavier
- Subjects
- *
SQUAMOUS cell carcinoma , *CANCER patients , *CANCER chemoprevention , *CANCER prognosis , *CLINICAL pathology , *IMMUNOHISTOCHEMISTRY , *PEROXISOMES , *GENE expression , *TONGUE cancer , *CANCER treatment - Abstract
Purpose: Peroxisome proliferator-activated receptor-γ (PPAR-γ) is a ligand-activated transcription factor, implicated in various aspects of cancer biology, such as differentiation, proliferation, invasion and angiogenesis. The present study aimed to evaluate the clinical significance of PPAR-γ in mobile tongue squamous cell carcinoma (SCC). Methods: PPAR-γ protein expression was assessed immunohistochemically on 49 mobile tongue SCC tissue samples obtained from an equal number of patients. PPAR-γ expression and intensity of immunostaining were statistically analyzed in relation with clinicopathological characteristics, mitotic index and patients' survival. Results: Elevated PPAR-γ expression was more frequently observed in patients with reduced depth of invasion ( P = 0.0111). Moderate/intense PPAR-γ staining intensity was more frequently observed in patients with no evidence of muscular infiltration ( P = 0.0229) and reduced depth of invasion ( P = 0.0176). Mobile tongue SCC patients presenting enhanced PPAR-γ expression had significantly longer overall and disease-free survival times compared to those with low PPAR-γ expression (log-rank test, P = 0.0162 and P = 0.0114, respectively). Conclusions: PPAR-γ immunoreactivity in mobile tongue SCC was correlated with clinicopathological characteristics crucial for patients' management and prognosis. PPAR-γ may be considered as a useful prognostic marker in mobile tongue SCC and a potential therapeutic target for tongue cancer chemoprevention and treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
18. Low Grade Myofibroblastic Sarcoma of the Tongue: A Case Report in an Infant
- Author
-
Boris Harold otouana Dzon, Gontran Ondzotto, Chidrel Gerard Ngouoni, Sylvain Diembi, Donatien Moukassa, and Franck Arnaud Itiere Odzili
- Subjects
0301 basic medicine ,Pathology ,medicine.medical_specialty ,Mitotic index ,business.industry ,Partial glossectomy ,03 medical and health sciences ,Low Grade Myofibroblastic Sarcoma ,030104 developmental biology ,0302 clinical medicine ,medicine.anatomical_structure ,Tongue ,030220 oncology & carcinogenesis ,Cytology ,medicine ,Immunohistochemistry ,Surgical excision ,business ,Mobile tongue - Abstract
A case of a 12-month-old male infant, who presented a painless swelling of the right anterolateral edge of the mobile tongue, is reported. The treatment consisted of a partial glossectomy with total surgical excision of the tumor. The diagnosis of low grade myofibroblastic sarcoma on the histological arguments (tumor architecture, cytology, mitotic index) and immunohistochemistry was retained.
- Published
- 2018
- Full Text
- View/download PDF
19. Human papillomavirus and p16 protein expression as prognostic biomarkers in mobile tongue cancer
- Author
-
Mitsuhiko Nakahira, Takashi Fujino, Kazuhiko Minami, Masanori Yasuda, Masashi Sugasawa, Yasuhiro Ebihara, and Yasunao Kogashiwa
- Subjects
Adult ,Male ,0301 basic medicine ,Oncology ,medicine.medical_specialty ,Biology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Multiplex polymerase chain reaction ,medicine ,Humans ,Human papillomavirus ,Papillomaviridae ,Cyclin-Dependent Kinase Inhibitor p16 ,Aged ,Retrospective Studies ,Oncogene ,Cancer ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,Head and neck squamous-cell carcinoma ,Tongue Neoplasms ,Survival Rate ,Reverse transcription polymerase chain reaction ,030104 developmental biology ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,Carcinoma, Squamous Cell ,Immunohistochemistry ,Female ,Tumor Suppressor Protein p53 ,Mobile tongue ,Biomarkers - Abstract
The objectives were to determine the prevalence of human papillomavirus (HPV) in mobile tongue cancer (MTC) and evaluate associations and survival.Patients who underwent surgical resection as primary treatment for MTC (n = 127) were retrospectively evaluated. Formalin-fixed paraffin-embedded (FFPE) specimens were assessed for p16 and p53 by immunohistochemistry; for HPV DNA by nested multiplex polymerase chain reaction (PCR) using two pairs of consensus primers (MY09-MY11 and GP5+-GP6+); and for E6 and E7 oncogenes from 13 high-risk HPV types (16, 18, 31, 33, 35, 39, 45, 52, 56, 58, 59, 66, and 68) by real-time reverse transcription PCR (RT-PCR).There were 18 (14.2%) p16-positive, 45 (35.4%) p53-positive, 9 (7.1%) HPV DNA-positive, and 7 (5.5%) E6 and/or E7 mRNA-positive tumors, but the correlation of all pairs was poor. There was no demographic or histopathologic association with HPV status. Cause-specific survival was significantly better with p16-positive than with p16-negative tumors (p = .037).The prevalence of HPV and p16 positivity was relatively low and p16 status was a poor surrogate marker for HPV status. The results showed the importance of p16 expression in prognosticating mobile tongue cancer.
- Published
- 2017
- Full Text
- View/download PDF
20. Expression and Clinical Significance of Concomitant FAK/SRC and p-Paxillin in Mobile Tongue Squamous Cell Carcinoma
- Author
-
Robert H.A. Coutts, Ioly Kotta-Loizou, Gerasimos Tsourouflis, Eugene Danas, Nikolaos Tsoukalas, Stamatios Theocharis, Paraskevi Alexandrou, Jason Tasoulas, Constantinos Giaginis, and Jerzy Klijanienko
- Subjects
Male ,0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,Kaplan-Meier Estimate ,Disease-Free Survival ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Humans ,Clinical significance ,Basal cell ,Paxillin ,Aged ,Proportional Hazards Models ,biology ,business.industry ,Cell Differentiation ,General Medicine ,Middle Aged ,Prognosis ,Immunohistochemistry ,Tongue Neoplasms ,Treatment Outcome ,src-Family Kinases ,030104 developmental biology ,Focal Adhesion Protein-Tyrosine Kinases ,Lymphatic Metastasis ,030220 oncology & carcinogenesis ,Concomitant ,Carcinoma, Squamous Cell ,Disease Progression ,biology.protein ,Female ,business ,Mobile tongue ,Proto-oncogene tyrosine-protein kinase Src - Abstract
The focal adhesion kinase (FAK)/SRC phosphorylation cascade and its downstream target paxillin have been implicated in malignant transformation, tumor growth and progression, together with metastasis. The present study aimed to evaluate the clinical significance of concomitant FAK/SRC and p-paxillin expression in mobile tongue squamous cell carcinoma (SCC).FAK, SRC and phospho-paxillin expression in 48 mobile tongue SCC tissue samples was assessed immunohistochemically and analyzed with respect to clinicopathological characteristics and patient survival.Concomitant high FAK/SRC expression was significantly associated with high grade of tumor differentiation (p=0.048) and longer disease-free patient survival (log-rank test, p=0.019). High p-paxillin expression was significantly associated with greater depth of invasion (p=0.002), lymph node metastasis (p=0.048) and poorer disease-free patient survival (log-rank test, p=0.021; Cox-regression analysis, p=0.031).The present study provides evidence that FAK/SRC and paxillin play a role in the pathophysiological aspects of mobile tongue SCC and could constitute therapeutic targets.
- Published
- 2017
- Full Text
- View/download PDF
21. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors
- Author
-
Marilena Vered and John M. Wright
- Subjects
medicine.medical_specialty ,Pathology ,Dentistry ,Bone Neoplasms ,Odontogenic Tumors ,World Health Organization ,Oral cavity ,World health ,Pathology and Forensic Medicine ,03 medical and health sciences ,0302 clinical medicine ,Bone tumours ,medicine ,Humans ,Head and neck ,Original Paper ,business.industry ,030206 dentistry ,Odontogenic ,Oncology ,Otorhinolaryngology ,Head and Neck Neoplasms ,030220 oncology & carcinogenesis ,Oral and maxillofacial surgery ,business ,Mobile tongue - Abstract
The 4th edition of the World Health Organization’s Classification of Head and Neck Tumours was published in January of 2017. This article provides a summary of the changes to Chapter 4 Tumours of the oral cavity and mobile tongue and Chapter 8 Odontogenic and maxillofacial bone tumours. Odontogenic cysts which were eliminated from the 3rd 2005 edition were included in the 4th edition as well as other unique allied conditons of the jaws. Many new tumors published since 2005 have been included in the 2017 classification.
- Published
- 2017
- Full Text
- View/download PDF
22. Keratin 36, a specific marker of tongue filiform papillae, is downregulated in squamous cell carcinoma of the mobile tongue
- Author
-
Nicola Sgaramella, Philip J. Coates, Veronika Brychtová, Pavel Fabian, Linda Boldrup, Karin Nylander, Václav Hrabal, and Borivoj Vojtesek
- Subjects
keratin 36 ,squamous cell carcinoma ,Cancer Research ,Pathology ,medicine.medical_specialty ,Biology ,Hair keratin ,03 medical and health sciences ,0302 clinical medicine ,Tongue ,thymus ,Keratin ,medicine ,Basal cell carcinoma ,nail ,chemistry.chemical_classification ,mobile tongue ,Cancer och onkologi ,integumentary system ,Cancer ,Articles ,medicine.disease ,Epithelium ,medicine.anatomical_structure ,Oncology ,chemistry ,030220 oncology & carcinogenesis ,Cancer and Oncology ,Immunohistochemistry ,030211 gastroenterology & hepatology ,Immunostaining - Abstract
Human keratin 36 (K36) is a member of the hair keratin family and is a marker of hair cortex differentiation. The human KRT36 gene is located on the long arm of chromosome 17 and belongs to the cluster of structurally unrelated acidic hair keratins. Recently, it has been reported that KRT36 mRNA is specifically expressed in normal tongue epithelium and downregulated in squamous cell carcinomas of the mobile tongue. Furthermore, KRT36 levels have been reported to be downregulated in clinically normal mobile tongue tissue that is adjacent to tumours, suggesting it could be a marker of pre-neoplastic changes. However, the exact role and the potential role of K36 in tongue tumour formation remains unclear. The aim of the present study was to investigate expression of K36 in a series of squamous cell carcinomas of the mobile tongue, normal mobile tongue and a small panel of other human tissues (normal tissue from the appendix, cervix, hair, lip, mamilla, nail, oesophagus, skin, thymus and vagina) and selected cancer tissue (cervical cancer, melanoma and basal cell carcinoma). Affinity purified polyclonal antibodies against K36 were generated and used for immunohistochemical analysis. The results revealed that in the normal tongue, K36 was detected specifically in the filiform papillae of the dorsal surface of the tongue. Additionally, none of the tongue cancer tissue samples were K36-positive. Immunostaining also revealed that K36 was expressed in nail beds, Hassal's corpuscles in the thymus and the hair cortex. However, K36 was not expressed in the squamous epithelia of the skin, cervix and oesophagus, and the squamous cells of cervical carcinomas, basal cell carcinoma or melanoma. The present data indicated that K36 may be inactivated in tumours of the tongue. However, whether this is part of the tumoural process or if it is an effect of the tumour itself remains to be elucidated.
- Published
- 2020
23. Neodymium YAG Contact Laser in the Treatment of Cancer of the Mobile Tongue.
- Author
-
Luukkaa, Marjaana, Aitasalo, Kalle, Pulkkinen, Jaakko, Lindholm, Paula, Valavaara, Ritva, and Grénman, Reidar
- Subjects
- *
ND-YAG lasers , *TONGUE cancer , *CANCER treatment , *THERAPEUTICS - Abstract
The aim of this study was to evaluate the usefulness of a contact neodymium YAG laser for the treatment of squamous cell carcinoma (SCC) of the mobile tongue in 35 patients. The TNM stage and histologic grade were as follows: T1, n = 20; T2, n = 11; T3, n = 4; and N0, n = 33; N1, n = 2; G1, n = 20; G2, n = 10; and G3, n = 5. The surgical treatment consisted of a hemiglossectomy or resection with adequate margins in 28 cases, and an ipsilateral neck dissection was also performed in 7 patients. Radiotherapy to a mean tumor dose of 62-64 Gy and an elective dose of 50 Gy to the cervical lymph nodes was given to 14 patients. The radiotherapy was preoperative in 12 patients and postoperative in 2. Tongue resection was easily performed using the contact neodymium YAG laser, with a mean operation time of 31 min and intraoperative bleeding varying from negligible to 100 cm[sup 3]. During postoperative follow-up no major complications occurred: cases with minor hemorrhage were easily controlled on the ward and 1 patient had a bleed on the 14th postoperative day necessitating hospitalization. The resection was histologically radical in all cases. During follow-up one patient had a local recurrence (T2N0, G3) and four failed in the neck (T1N0 G2, T1N0 G2, T1N0 G2, T2N0 G2), three of whom were successfully salvaged with a neck dissection and radiotherapy. One patient with osteoradionecrosis was diagnosed and treated curatively. Two patients died of their tongue cancer (T2N0 G3, T2N0 G2), 1 died from a second primary tumor (T2N0 G1) and 2 of intercurrent disease with no evidence of cancer; 30 patients (86%) are still alive with no evidence of disease. The function of the tongue in all patients in this sample was good to satisfactory. The major complaint was xerostomia in the irradiated patients. In conclusion, the contact neodymium YAG laser appears to be suitable for resection of T1-T2 SCCs of the oral tongue. In this limited patient sample T stage or grade did not predict failures in the neck. Biologic predictive markers need to be evaluated. [ABSTRACT FROM AUTHOR]
- Published
- 2002
- Full Text
- View/download PDF
24. Edema worsens target coverage in high-dose-rate interstitial brachytherapy of mobile tongue cancer: a report of two cases
- Author
-
T. Shimbo, N. Yoshikawa, Yoshifumi Narumi, Eiichi Tanaka, Takumi Arika, Tadayuki Kotsuma, Hironori Akiyama, Yasuo Uesugi, Hiroto Yoshioka, Ken Yoshida, Koji Masui, Hideya Yamazaki, Yasuo Yoshioka, and Tadashi Takenaka
- Subjects
0106 biological sciences ,medicine.medical_specialty ,medicine.medical_treatment ,Brachytherapy ,lcsh:Medicine ,Case Report ,HDR ,01 natural sciences ,03 medical and health sciences ,0302 clinical medicine ,Tongue ,Edema ,Medicine ,Radiology, Nuclear Medicine and imaging ,business.industry ,Interstitial brachytherapy ,lcsh:R ,tongue cancer ,Cancer ,medicine.disease ,Surgery ,Splints ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,Radiology ,medicine.symptom ,business ,Dose rate ,Mobile tongue ,edema ,target coverage ,010606 plant biology & botany - Abstract
Purpose : We report our study on two patients to highlight the risk of underdosage of the clinical target volume (CTV) due to edema during high-dose-rate interstitial brachytherapy (HDR-ISBT) of mobile tongue cancer. Material and methods : To treat the lateral side of the CTV, flexible applicator tubes were implanted on the mouth floor. Two-dimensional planning was performed using X-ray images for Case 1, and three-dimensional (3D) planning was performed using computed tomography (CT) for Case 2. Prescribed doses for both cases were 54 Gy in nine fractions. Case reports : Case 1 was treated for cancer of the right lateral border of the tongue in 2005. Tongue edema occurred after implantation, and part of the lateral border of the tongue protruded between the applicator tubes. Acute mucosal reaction abated in the protruded area earlier than in the other parts of the CTV. In this case, the tumor recurred in this area 5 months after the treatment. Case 2 was treated for cancer of the left lateral border of the tongue. Because tongue edema occurred in this case also, plastic splints were inserted between the applicator tubes to push the edematous region into the irradiated area. The mucosal surface of the CTV was covered by the 70% isodose, and 100% isodose line for before and after splint insertion. Local control of the tumor was achieved 4 years after treatment. Discussion and conclusions : To ensure sufficient target coverage, 3D image-based planning using CT should be performed, followed by re-planning using repeated CT as needed. Also, the development of devices to prevent protrusion of the edematous tissue outside the target area will help to ensure the full dosing of CTV.
- Published
- 2017
25. Cancers de la cavité buccale chez les sujets jeunes : résultats thérapeutiques et analyse de facteurs pronostiques
- Author
-
F. Nguyen, Pierre Blanchard, Yungan Tao, François Janot, Caroline Even, Stéphane Temam, Odile Casiraghi, Antonin Levy, P. Gorphe, C. El Khoury, F. De Felice, and Haitham Mirghani
- Subjects
Mouth neoplasm ,Gynecology ,Disease free survival ,medicine.medical_specialty ,business.industry ,030206 dentistry ,Oral cavity ,03 medical and health sciences ,0302 clinical medicine ,Oncology ,030220 oncology & carcinogenesis ,Medicine ,Radiology, Nuclear Medicine and imaging ,business ,Mobile tongue - Abstract
Resume Objectifs de l’etude Les carcinomes epidermoides de la cavite buccale du sujet jeune constituent une entite specifique dont la prise en charge et le pronostic sont discutes. Nous avons effectue une analyse retrospective des dossiers de l’ensemble des patients âges de moins de 40 ans et pris en charge a Gustave-Roussy pour un carcinome epidermoide de la cavite buccale entre 1999 et 2011. Methodes Les caracteristiques des patients, des tumeurs, du traitement, et le devenir ont ete enregistres. Une analyse de survie par la methode de Kaplan-Meier a ete realisee, ainsi qu’une analyse unifactorielle et multifactorielle a la recherche de facteurs pronostiques de la survie globale et la survie sans progression. Resultats Soixante-trois patients ont ete identifies. Le suivi median etait de 64 mois. La majorite des tumeurs siegeait au niveau de la langue mobile (n = 54, 86 %). Au total 17 patients sont decedes, dont 15 du cancer traite. Les taux de survie globale et sans progression a 5 ans etaient de 80 % et 69 %. Les taux de survie sans rechute locale, regionale ou metastatique a 5 ans etaient de 80 %, 91 % et 89 %. En analyse multifactorielle, seule l’absence de chirurgie initiale etait pronostique pour la survie globale (hazard ratio [HR] : 13,5 [2,0 ; 90,5], p = 0,007), tandis que la consommation d’alcool (HR : 0,38 [0,15 ; 0,9], p = 0,03) et l’absence de chirurgie (HR : 9,8 [1,9 ; 50,9], p = 0,006) etaient associees a une diminution de la probabilite de survie sans progression. Un âge plus jeune (moins de 30 ans) n’etait pas associe ni a la survie globale ni a celle sans progression. Conclusion Les taux de survie et de controle tumoral sont relativement eleves chez les sujets jeunes atteints de carcinome epidermoide de la cavite buccale traites dans un centre tertiaire. L’identification pretherapeutique des sujets a risque de recidive est actuellement difficile. La balance entre risque de rechute et toxicite des traitements justifie la realisation d’etudes supplementaires, sur le plan clinique et pour le developpement de biomarqueurs pronostiques.
- Published
- 2016
- Full Text
- View/download PDF
26. Convergence of macroscopic tongue anatomy in ruminants and scaling relationships with body mass or tongue length
- Author
-
Marcus Clauss, Reinhold R. Hofmann, Andrea R. Meier, Ute Schmuck, and Carlo Meloro
- Subjects
0106 biological sciences ,0301 basic medicine ,Anatomy ,Biology ,Body size ,Functional interpretation ,010603 evolutionary biology ,01 natural sciences ,03 medical and health sciences ,030104 developmental biology ,medicine.anatomical_structure ,Tongue ,medicine ,Animal Science and Zoology ,Akaike information criterion ,Snout ,Mobile tongue ,Scaling ,Body condition ,Developmental Biology - Abstract
Various morphological measures demonstrate convergent evolution in ruminants with their natural diet, in particular with respect to the browser/grazer dichotomy. Here, we report quantitative macroanatomical measures of the tongue (length and width of specific parts) of 65 ruminant species and relate them to either body mass (BM) or total tongue length, and to the percentage of grass in the natural diet (%grass). Models without and with accounting for the phylogenetic structures of the dataset were used, and models were ranked using Akaike's Information Criterion. Scaling relationships followed geometric principles, that is, length measures scaled with BM to the power of 0.33. Models that used tongue length rather than BM as a body size proxy were consistently ranked better, indicating that using size proxies that are less susceptible to a wider variety of factors (such as BM that fluctuates with body condition) should be attempted whenever possible. The proportion of the freely mobile tongue tip of the total tongue (and hence also the corpus length) was negatively correlated to %grass, in accordance with concepts that the feeding mechanism of browsers requires more mobile tongues. It should be noted that some nonbrowsers, such as cattle, use a peculiar mechanism for grazing that also requires long, mobile tongues, but they appear to be exceptions. A larger corpus width with increasing %grass corresponds to differences in snout shape with broader snouts in grazers. The Torus linguae is longer with increasing %grass, a finding that still warrants functional interpretation. This study shows that tongue measures covary with diet in ruminants. In contrast, the shape of the tongue (straight or "hourglass-shaped" as measured by the ratio of the widest and smallest corpus width) is unrelated to diet and is influenced strongly by phylogeny.
- Published
- 2015
- Full Text
- View/download PDF
27. Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1
- Author
-
Christos Loizou, Philip J. Coates, Lorenzo Lo Muzio, Göran Laurell, Klas Strindlund, Katarina Olofsson, Karin Nylander, Nicola Sgaramella, Lotta Loljung, Robin Fåhraeus, Giuseppe Colella, Gianpaolo Tartaro, Riccardo Rossiello, Karin Danielsson, Sgaramella, N, Coates, P. J, Strindlund, K, Loljung, L, Colella, Giuseppe, Laurell, G, Rossiello, R, Muzio, L. L, Loizou, C, Tartaro, Gianpaolo, Olofsson, K, Danielsson, K, Fåhraeus, R, and Nylander, K.
- Subjects
squamous cell carcinoma ,Adult ,Male ,Oncology ,HPV ,Cancer Research ,medicine.medical_specialty ,Tongue squamous cell carcinoma ,p16 ,Biology ,Syndecan 1 ,Neoplasm Protein ,tongue ,Internal medicine ,Receptors, Viru ,medicine ,Humans ,Basal cell ,Tongue Neoplasm ,Receptor ,Molecular Diagnostics ,Papillomavirus Infection ,Cyclin-Dependent Kinase Inhibitor p16 ,In Situ Hybridization ,Aged ,Aged, 80 and over ,Human papillomavirus 16 ,Squamous Cell Carcinoma of Head and Neck ,Head and Neck Neoplasm ,Incidence (epidemiology) ,Papillomavirus Infections ,HPV infection ,virus diseases ,Middle Aged ,medicine.disease ,female genital diseases and pregnancy complications ,Neoplasm Proteins ,Tongue Neoplasms ,3. Good health ,stomatognathic diseases ,Head and Neck Neoplasms ,DNA, Viral ,Carcinoma, Squamous Cell ,Receptors, Virus ,Female ,Syndecan-1 ,Mobile tongue ,Human - Abstract
Background: Tongue squamous cell carcinoma (TSCC) is increasing in incidence, especially among young patients and preferably females. Infection with human papilloma virus (HPV) has been suggested as a cause of SCC in the head and neck, and the proportion of oropharyngeal cancers caused by HPV has steadily increased. Methods: Samples from 109 patients with primary TSCC were analysed for the presence of HPV16 by in situ hybridisation and for expression of its surrogate marker p16 and the HPV receptor syndecan-1 by immunhistochemistry. Results: No evidence of HPV16 DNA was observed in the tumours, although one-third showed p16 staining. There was no difference in the expression of the primary HPV receptor, syndecan-1, between TSCC and a group of tonsil SCC. Conclusion: Whereas p16 is expressed in some TSCCs, HPV16 is undetectable, therefore, p16 cannot be used as a surrogate marker for high-risk HPV-infection in this tumour. Despite presence of the HPV-receptor syndecan-1 in TSCC, HPV prefers the tonsillar environment. Lack of p16 associates with worse prognosis primarily in patients aged ⩽40 years with tongue SCC. The improved prognosis seen in p16-positive TSCC can be due to induction of a senescent phenotype or an inherent radiosensitivity due to the ability of p16 to inhibit homologous recombination repair.
- Published
- 2015
- Full Text
- View/download PDF
28. Research on color correction algorithm for mobile-end tongue images
- Author
-
Jun-wei Xie, Rong Chen, and Cuihua Li
- Subjects
Retinex algorithm ,Mobile end ,Signal processing ,medicine.anatomical_structure ,Computer science ,Tongue ,Color correction ,ComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISION ,medicine ,Mobile device ,Mobile tongue ,Algorithm ,Visualization - Abstract
Shadows and chromatic aberration problems are existed in the mobile tongue images, which result in tongue images obtained from the mobile devices cannot be directly used for auxiliary diagnosis. To better acquire the color features of the tongue images, we analyze the HIT tongue database and our mobile tongue dataset. Comparing to the HIT tongue database, we found insufficient exposure might be the root cause of above problems in the mobile tongue dataset. Therefore, we propose a two-stage color correction algorithm to effectively solve two problems. To remove the shadows in the tongue images, Frankle-McCann retinex algorithm is implemented. Then, to restore the whole color distribution of the tongue images as real world, the gray world algorithm is utilized to fine-tune the color values of the tongue images. Qualitative and quantitative analysis show that the proposed algorithm can achieve good objective and real visual results.
- Published
- 2017
- Full Text
- View/download PDF
29. High-dose-rate interstitial brachytherapy for mobile tongue cancer: preliminary results of a dose reduction trial
- Author
-
Kimishige Shimizutani, Ken Yoshida, Takumi Arika, Hideya Yamazaki, Eiichi Tanaka, Koji Masui, Yasuo Yoshioka, Tadayuki Kotsuma, Hironori Akiyama, and Tadashi Takenaka
- Subjects
medicine.medical_specialty ,Original Paper ,business.industry ,medicine.medical_treatment ,Interstitial brachytherapy ,Brachytherapy ,tongue cancer ,Cancer ,medicine.disease ,High-Dose Rate Brachytherapy ,Surgery ,Oncology ,dose reduction ,high-dose-rate brachytherapy ,medicine ,Radiology, Nuclear Medicine and imaging ,Dose reduction ,Adverse effect ,business ,Nuclear medicine ,Survival rate ,Mobile tongue - Abstract
Purpose: To compare the outcome of our facility with another about the shortened schedule (60 Gy in 10 fractions to 54 Gy in 9 fractions) of high-dose-rate interstitial brachytherapy (HDR ISBT) for mobile tongue cancer. Material and methods: Eighteen patients were treated with HDR ISBT as a monotherapy in dose reduction schedule with some unique technique to determine the border of tumor accuracy (lugol’s staining and metal marker), and to minimize adverse effect (lead-lined silicon block) at our facility. Results: The 2-year local and regional control rates and cause-specific survival rate were 82%, 80%, and 83% and moderate to severe late complications occurred in five patients (28%), which were almost the same treatment results achieved by another facility. Conclusions: We recommend 54 Gy in 9 fractions over 7 days as a feasible treatment to reduce patient discomfort in mobile tongue cancer patients. J Contemp Brachytherapy 2014; 6, 1: 10–14 DOI: 10.5114/jcb.2014.40726
- Published
- 2014
30. Treatment of adenoid cystic carcinoma of the mobile tongue with anterolateral thigh flap reconstruction
- Author
-
Chengyao Zhang, Rui Chen, Xi Tang, Yulian Zhang, and Xiaohong Zhou
- Subjects
Thigh surgery ,medicine.medical_specialty ,business.industry ,Adenoid cystic carcinoma ,Perineural invasion ,General Medicine ,Anterolateral thigh ,medicine.disease ,behavioral disciplines and activities ,Slow growth ,stomatognathic diseases ,Carcinoma ,Medicine ,Radiology ,business ,Mobile tongue ,Pathological - Abstract
Rationale:Adenoid cystic carcinoma (ACC) is an infrequent malignant neoplasm of the salivary glands. The clinical and pathological characteristics include slow growth, perineural invasion, and local recurrence. ACC of the mobile tongue is rarely reported in the literature.Patient concerns:We
- Published
- 2019
- Full Text
- View/download PDF
31. A fish bone embedded in the mobile tongue mimicking a neoplasm.
- Author
-
Wang, Yan and Li, Wen
- Subjects
CASE studies ,TONGUE surgery ,TONGUE diseases ,FOREIGN bodies ,BIOPSY ,TUMORS ,LARYNGOSCOPY ,ENDOSCOPY ,PHARYNGEAL bursa ,GRANULOMA ,DIAGNOSIS - Abstract
Foreign bodies embedded in a mobile tongue as an enlarged tongue mass are rarely presented to either a laryngologist or a dentist, because such bodies are commonly lodged superficially and are easily removed by the patients themselves or removed by a laryngologist by means of indirect laryngoscope or endoscope. We have described a 63-year-old female with an 8-month history of an enlarged mass in the anterior right tongue. Physical examination demonstrated a mass located in the anterior right tongue without clear margin, with superficially intact mucosa and normal colour. A benign tongue neoplasm was first considered. However, a fish bone totally embedded in the mobile tongue with granuloma formation was encountered during the incisional biopsy operation. Complete removal of the foreign body with granuloma was achieved under general anaesthesia. There was no neuromuscular or neurosensory dysfunction of the tongue in the follow-up period of 2 years. Although an embedded foreign body in the mobile tongue is a rare condition, it should be considered in the work-up of a patient with an enlarged tongue mass, with or without a history of swallowing a foreign body. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
32. A foreign body embedded in the mobile tongue masquerading as a neoplasm.
- Author
-
Chao-Jung Lin, Wan-Fu Su, and Chih-Hung Wang
- Subjects
- *
TONGUE cancer , *TUMORS , *GRANULOMA , *BIOPSY , *CLINICAL pathology , *LOCAL anesthesia , *OTOLARYNGOLOGY - Abstract
Foreign bodies in a mobile tongue are rarely presented to the laryngologist, because such bodies are commonly lodged superficially and are easily removed by the patients themselves or by general practitioners. Thus, it is rare that a foreign body totally embedded in the mobile part of the tongue presents as an enlarged tongue mass. We have described a 64-year-old female with a 3-month history of an enlarged mass in the anterior right tongue. Physical examination showed a mass located in the anterior right tongue, with intact mucosa and normal color. A benign tongue neoplasm was considered first. However, a fish bone totally embedded in the mobile tongue with granuloma formation was encountered during the incisoinal biopsy operation. Complete removal of the foreign body with granuloma was achieved under local anesthesia. There was no neuromuscular or neurosensory deficit of the tongue in the follow-up period of 2 years. Although an embedded foreign body in the mobile tongue is a rare condition, it should be considered in the work-up of a patient with an enlarged tongue mass, with or without a history of swallowing a foreign body. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
33. The palatal dentition of tetrapods and its functional significance
- Author
-
Susan E. Evans and Ryoko Matsumoto
- Subjects
0106 biological sciences ,010506 paleontology ,Histology ,Biology ,Extinction, Biological ,010603 evolutionary biology ,01 natural sciences ,stomatognathic system ,Animals ,Dentition ,Molecular Biology ,Ecology, Evolution, Behavior and Systematics ,Phylogeny ,0105 earth and related environmental sciences ,Orthodontics ,Palate ,Single factor ,Cell Biology ,Original Articles ,Biological Evolution ,Vertebrates ,Functional significance ,Anatomy ,Mobile tongue ,Tooth ,Developmental Biology - Abstract
The presence of a palatal dentition is generally considered to be the primitive condition in amniotes, with each major lineage showing a tendency toward reduction. This study highlights the variation in palatal tooth arrangements and reveals clear trends within the evolutionary history of tetrapods. Major changes occurred in the transition between early tetrapods and amphibians on the one hand, and stem amniotes on the other. These changes reflect the function of the palatal dentition, which can play an important role in holding and manipulating food during feeding. Differences in the arrangement of palatal teeth, and in their pattern of loss, likely reflect differences in feeding strategy but also changes in the arrangement of cranial soft tissues, as the palatal dentition works best with a well-developed mobile tongue. It is difficult to explain the loss of palatal teeth in terms of any single factor, but palatal tooth patterns have the potential to provide new information on diet and feeding strategy in extinct taxa.
- Published
- 2016
34. The facial artery musculomucosal flap: Modification of the harvesting technique for a single-stage procedure
- Author
-
Tareck Ayad and Maxime Duranceau
- Subjects
medicine.medical_specialty ,Surgical approach ,Single stage ,business.industry ,Facial artery ,Oral cavity ,Surgery ,stomatognathic diseases ,medicine.anatomical_structure ,Otorhinolaryngology ,Tongue ,medicine.artery ,medicine ,business ,Mobile tongue - Abstract
INTRODUCTION The facial artery musculomucosal (FAMM) flap was first described in 1992 by Pribaz et al. This flap allows reconstruction of smallto medium-size oral cavity, oropharynx, and intranasal defects. Lateral and anterior floor-of-mouth (FOM) defects have been successfully reconstructed with the FAMM flap, maintaining the tongue mobility and ensuring adequate elocution and the oral phase of deglutition. The FAMM flap can also be used for reconstructions of other subsites of the oral cavity as well as the lip and vermillion reconstruction. However, a second-stage procedure is often needed to reduce the bulky mucosal paddle at the base of the flap, to increase the depth of the vestibule and to allow greater mobility of the mobile tongue. A second-stage procedure is required in approximately one third of the patients. We present herein a modification of the surgical approach of the FAMM flap to allow a one-stage procedure and the surgical outcomes in three cases.
- Published
- 2011
- Full Text
- View/download PDF
35. Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival
- Author
-
Thomas Jouffroy, Constantinos Giaginis, José Rodriguez, Point D, Gerasimos Tsourouflis, Angélique Girod, Jerzy Klijanienko, Xavier Sastre-Garau, and Stamatios Theocharis
- Subjects
Pathology ,medicine.medical_specialty ,Histology ,Cancer ,General Medicine ,Biology ,medicine.disease ,Pathology and Forensic Medicine ,Staining ,medicine.anatomical_structure ,Apoptosis ,medicine ,Metallothionein ,Immunohistochemistry ,Clinical significance ,Lymph node ,Mobile tongue - Abstract
Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, Point D, Tsourouflis G & Sastre-Garau X (2011) Histopathology59, 514–525 Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival Aims: Metallothionein (MT) has been implicated in several aspects of cancer pathobiology, such as differentiation, proliferation, apoptosis and invasion. The aim of the present study was to evaluate the clinical significance of MT expression in mobile tongue squamous cell carcinoma (SCC). Methods and results: MT protein expression was assessed immunohistochemically on 49 mobile tongue SCC specimens, and was analysed in relation to clinicopathological characteristics, and overall and disease-free patient survival. All of the examined mobile tongue SCC cases showed MT positivity in tumour cells; however, neither MT overexpression nor staining intensity was significantly associated with clinicopathological parameters. MT cellular distribution was significantly associated with histopathological grade of differentiation and depth of invasion (P = 0.0188 and P = 0.0484, respectively). MT staining intensity was identified as a significant predictor of overall patient survival at both univariate (P = 0.0377) and multivariate (P = 0.0472) levels. Twenty-seven (55.10%) of the examined SCC cases showed MT positivity in squamous tongue epithelium adjacent to the tumour, the MT positivity being correlated with depth of invasion (P = 0.0281), vascular invasion (P = 0.0194), and the existence of lymph node metastases (P = 0.0194). Conclusions: MT may be implicated in the development and progression of mobile tongue SCC and could be considered as a useful clinical marker for patient management and prognosis.
- Published
- 2011
- Full Text
- View/download PDF
36. Orofacial Impactions: A Common Rarity
- Author
-
Freny R Karjodkar, Sunali Khanna, and Darshana J. Patil
- Subjects
Orthodontics ,Maxillary sinus ,business.industry ,Impaction ,Electronic journal ,Dentistry ,stomatognathic diseases ,medicine.anatomical_structure ,stomatognathic system ,Otorhinolaryngology ,Tongue ,medicine ,business ,Mobile tongue - Abstract
Impactions of the orofacial region are rare but impactions of the mobile tongue are unique. Hence, very limited literature is available. Foreign bodies embedded in the maxillofacial region frequently result from trauma and dental treatment. This is a compilation of cases of tongue impaction, tooth in maxillary sinus and watch battery impacted in tooth. A brief insight into the incidence of orofacial impactions, radiographic investigations and management is also provided.
- Published
- 2011
- Full Text
- View/download PDF
37. Initial Swallowing Function in those Undergoing Subtotal Mobile Tongue^|^ndash;Component Resection and Reconstruction with a Myocutaneous Pectoralis Major Flap
- Author
-
Noritaka Isogai, Kazunori Mori, Mitsuhiro Wada, Shinichi Asamura, and Kazuhide Matsunaga
- Subjects
Pectoralis major flap ,medicine.medical_specialty ,Swallowing ,business.industry ,Component (UML) ,Medicine ,business ,Mobile tongue ,Resection ,Surgery - Published
- 2011
- Full Text
- View/download PDF
38. Oral cavity cancers among young people: clinical results and prognostic analysis Cancers de la cavité buccale chez les sujets jeunes: Résultats thérapeutiques et analyse de facteurs pronostiques
- Author
-
Blanchard, P, El Khoury, C., Temam, S., Casiraghi, O., Mirghani, H., Lévy, A., Gorphe, P., Éven, C., DE FELICE, Francesca, Nguyen, F., Janot, F., and Tao, Y.
- Subjects
squamous cell carcinoma ,combined modality therapy ,disease-free survival ,carcinoma ,chemotherapy ,surgery ,nuclear medicine and imaging ,male ,humans ,medicine (all) ,radiotherapy ,mobile tongue ,alcoholism ,young ,squamous cell ,adult ,mouth neoplasms ,radiology ,retrospective studies ,female ,multivariate analysis ,oncology ,young adult ,oral cavity ,carcinoma, squamous cell ,france ,prognosis ,radiology, nuclear medicine and imaging - Published
- 2016
39. Ultrasonography-guided interstitial brachytherapy using Iridium hairpins for stage I and II squamous cell carcinoma of the mobile tongue
- Author
-
Katsuhide Ito, Yuuji Murakami, Yuuko Kaneyasu, Masahiro Kenjyo, Kanji Matsuura, Minoru Fujita, Kouichi Wadasaki, and Shintarou Yuki
- Subjects
medicine.medical_specialty ,Oncology ,Otorhinolaryngology ,business.industry ,Interstitial brachytherapy ,Medicine ,Basal cell ,Radiology ,Ultrasonography ,business ,Mobile tongue ,Surgery - Abstract
1994~2005年にイリジウムヘアピンを用いた低線量率組織内照射を行った早期舌癌152例のうち,2004年以降に治療した20例に対して刺入操作中に超音波検査を行うことによって腫瘍に対する線源位置の改善を図った。この超音波検査が治療成績に与えた影響を検討した。局所再発は2003年以前では全例中17例(13%)に生じていたが,2004年以降では1例(5%)へと減少した。特にT2症例では14例の全例が制御された。放射線潰瘍は2003年以前では64例(57%)に生じていたが,2004年以降では9例(47%)に減少した。放射線潰瘍は1例を除き全例で保存的療法により6ヶ月未満で消退した。刺入操作中に超音波検査により線源位置を確認することによって腫瘍に対して確実に線量を投与できたことが局所制御の向上に寄与したものと思われた。
- Published
- 2007
- Full Text
- View/download PDF
40. Adenoid cystic carcinoma: A rare late presentation of the mobile tongue
- Author
-
Sanjay Kumar, V. Nimmi, and Padmanidhi Agarwal
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Adenoid cystic carcinoma ,Magnetic resonance imaging ,Case Report ,medicine.disease ,Surgery ,Lesion ,Late presentation ,030207 dermatology & venereal diseases ,03 medical and health sciences ,stomatognathic diseases ,0302 clinical medicine ,Fine-needle aspiration ,medicine.anatomical_structure ,Otorhinolaryngology ,Tongue ,medicine ,medicine.symptom ,business ,General Dentistry ,Mastication ,Mobile tongue ,human activities - Abstract
Adenoid cystic carcinoma (ACC) is an infrequent malignant neoplasm of the salivary glands. We present a case of a 70-year-old male patient with a swelling over the dorsal and ventral surface of anterior two third of the tongue which was causing him difficulty in mastication since 10 months. Ultrasound and magnetic resonance imaging were done following which the surgical excision of the lesion was performed and histopathological diagnosis of ACC was achieved. It was rare to find ACC in such an old man with such a large lesion presenting so late in the rare site of the mobile tongue. ACC is a slowly growing, highly invasive cancer with a high recurrence rate and chances of metastases, so surgery is the choice of treatment with mandatory long-term follow-up.
- Published
- 2015
41. Late complications after high-dose-rate interstitial brachytherapy for tongue cancer
- Author
-
Souhei Furukawa, Toshihiko Inoue, Yasuo Yoshioka, Naoya Kakimoto, Shumei Murakami, Hajime Fuchihata, Kimishige Shimizutani, Takehiro Inoue, and Teruki Teshima
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Brachytherapy ,Interstitial brachytherapy ,Cancer ,Treatment results ,medicine.disease ,Surgery ,medicine.anatomical_structure ,Tongue ,medicine ,Oral and maxillofacial surgery ,Radiology, Nuclear Medicine and imaging ,Dentistry (miscellaneous) ,Dose rate ,business ,Mobile tongue - Abstract
Objectives To analyze the treatment results and late complications of high-dose-rate (HDR) interstitial brachytherapy (ISBT) for early (T1N0, T2N0) mobile tongue cancer using the microSelectron-HDR.
- Published
- 2005
- Full Text
- View/download PDF
42. ASSESSMENT OF RECONSTRUCTION FOLLOWING HEMIGLOSSECTOMY OF LIMITED MOBILE TONGUE
- Author
-
Kenji Sagou, Hiroyuki Ishikawa, Akihisa Horie, Gorou Watanabe, Naoki Iida, Kanichi Seto, K. Kawaguchi, Hideki Sekiya, Hiroyuki Yamada, Masarou Matsuura, Junichi Satou, and Susumu Iketani
- Subjects
Orthodontics ,business.industry ,Medicine ,business ,Mobile tongue - Published
- 2004
- Full Text
- View/download PDF
43. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer
- Author
-
Souhei Furukawa, Kimishige Shimizutani, Yasuo Yoshioka, Naoya Kakimoto, Eiichi Tanaka, Takehiro Inoue, Shumei Murakami, Hideya Yamazaki, Ken Yoshida, and Toshihiko Inoue
- Subjects
Adult ,Male ,medicine.medical_treatment ,Brachytherapy ,Tongue ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,External beam radiotherapy ,Radiation Injuries ,Survival rate ,Aged ,Aged, 80 and over ,business.industry ,Interstitial brachytherapy ,Cancer ,Radiotherapy Dosage ,Hematology ,Middle Aged ,Iridium Radioisotopes ,medicine.disease ,Tongue Neoplasms ,Survival Rate ,Radiation therapy ,medicine.anatomical_structure ,Oncology ,Lymphatic Metastasis ,Carcinoma, Squamous Cell ,Female ,Neoplasm Recurrence, Local ,business ,Nuclear medicine ,Mobile tongue - Abstract
Purpose : To evaluate the treatment results of low-dose-rate (LDR) and high-dose-rate (HDR) interstitial brachytherapy (ISBT) for T3 mobile tongue cancer. Material and methods : Between 1974 and 1992, 61 patients with T3 mobile tongue cancer were treated with LDR ISBT using 192 Ir hairpins with or without single pins. In addition, between 1991 and 1999, 14 patients were treated with HDR ISBT. For nine patients treated with ISBT alone, the total dose was 59–94 Gy (median 72 Gy) within one week in LDR ISBT and 60 Gy/10 fractions/5 days in HDR ISBT. For 66 patients treated with a combination therapy of external beam radiotherapy (EBRT) and ISBT, the total dose was 12.5–60 Gy (median 30 Gy) of EBRT and 50–112 Gy (median 68 Gy) within 1 week in LDR ISBT or 32–60 Gy (median 48 Gy)/8–10 fractions/5–7 days in HDR ISBT. Results : The 2- and 3-year local control rates of all patients were both 68%. The 2- and 3-year local control rates of patients treated with LDR ISBT were both 67%, and those with HDR ISBT were both 71%. The local control rate of patients treated with HDR ISBT was similar to those with LDR ISBT. Conclusions : ISBT for T3 mobile tongue cancer is effective and acceptable. The treatment result of HDR ISBT is almost similar to that of LDR ISBT for T3 mobile tongue cancer.
- Published
- 2003
- Full Text
- View/download PDF
44. Interstitial brachytherapy for carcinoma of the tongue using microSelectron-HDR
- Author
-
Souhei Furukawa, Naoya Kakimoto, Kimishige Shimizutani, Toshihiko Inoue, Shumei Murakami, Takehiro Inoue, Yoshihiro Tanaka, Ken Yoshida, and Yonoshin Koseki
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Brachytherapy ,Interstitial brachytherapy ,Treatment results ,medicine.disease ,Radiation therapy ,medicine.anatomical_structure ,Tongue ,Internal medicine ,Carcinoma ,medicine ,Radiology, Nuclear Medicine and imaging ,Dentistry (miscellaneous) ,Dose rate ,Nuclear medicine ,business ,Mobile tongue - Abstract
Objectives To analyse the treatment results of high dose rate (HDR) interstitial brachytherapy (ISBT) for early (T1N0, T2N0) mobile tongue cancer using microSelectron-HDR.
- Published
- 2001
- Full Text
- View/download PDF
45. Expression of Cytokeratin Subtypes and Vimentin in Squamous Cell Carcinoma of the Floor of the Mouth and the Mobile Tongue
- Author
-
Wim Kuijpers, H. Ewout Schaafsma, Lilly-Ann van der Velden, Johannes J. Manni, and Frans C. S. Ramaekers
- Subjects
Pathology ,medicine.medical_specialty ,Floor of mouth ,Cell ,Vimentin ,macromolecular substances ,Biology ,Oral cavity ,Epithelium ,Cytokeratin ,medicine.anatomical_structure ,Otorhinolaryngology ,medicine ,biology.protein ,Basal cell ,Mobile tongue - Abstract
Objectives: The assessment of the expression patterns of cytokeratin polypeptides (Cks) and vimentin in normal epithelium of the mobile tongue and floor of the mouth, squamous cell carcinomas and their lymph node metastases. Material and Methods: Chain-specific monoclonal antibodies to various Cks and vimentin were used, employing the immunoperoxidase technique. Results and Conclusions: Profound changes in the expression of pre-existing Cks and de novo expression of simple epithelium-related Cks and of vimentin occurred upon malignant transformation and tumor progression. Changes were mainly related to the degree of cellular differentiation, tumor cell morphology and tumor growth pattern. Low-grade tumors showed a pronounced decrease of the stratification Cks 4 and 13, and an increase of Cks 14, 16, and 17. With increasing tumor grade, expression of Cks 16 and 17 decreased. De novo expression of Cks 8 and 18 and of vimentin was most marked in high-grade tumors, in tumors with a basaloid phenotype and in tumors growing in small infiltrating tumor fields; it was proposed to be associated with poor prognosis.
- Published
- 2001
- Full Text
- View/download PDF
46. A fish bone embedded in the mobile tongue mimicking a neoplasm
- Author
-
Wen Li and Yan Wang
- Subjects
medicine.medical_specialty ,Endoscope ,business.industry ,Anatomy ,medicine.disease ,Surgery ,medicine.anatomical_structure ,Swallowing ,Tongue ,Granuloma ,medicine ,Benign Tongue Neoplasm ,Oral Surgery ,Foreign body ,business ,Mobile tongue ,Fish bone - Abstract
Foreign bodies embedded in a mobile tongue as an enlarged tongue mass are rarely presented to either a laryngologist or a dentist, because such bodies are commonly lodged superficially and are easily removed by the patients themselves or removed by a laryngologist by means of indirect laryngoscope or endoscope. We have described a 63-year-old female with an 8-month history of an enlarged mass in the anterior right tongue. Physical examination demonstrated a mass located in the anterior right tongue without clear margin, with superficially intact mucosa and normal colour. A benign tongue neoplasm was first considered. However, a fish bone totally embedded in the mobile tongue with granuloma formation was encountered during the incisional biopsy operation. Complete removal of the foreign body with granuloma was achieved under general anaesthesia. There was no neuromuscular or neurosensory dysfunction of the tongue in the follow-up period of 2 years. Although an embedded foreign body in the mobile tongue is a rare condition, it should be considered in the work-up of a patient with an enlarged tongue mass, with or without a history of swallowing a foreign body.
- Published
- 2008
- Full Text
- View/download PDF
47. Nectarivorous feeding mechanisms in bats
- Author
-
Patricia W. Freeman
- Subjects
Frugivore ,biology ,Functional morphology ,Zoology ,Insectivore ,Anatomy ,Narrow head ,biology.organism_classification ,Mobile tongue ,Ecology, Evolution, Behavior and Systematics ,Glossophaginae - Abstract
Cranio-dental characteristics are quantified between micro- and megachiropteran nectarivores and compared with microchiropteran animalivores, frugivores, and megachiropteran frugivores. Microchiropteran nectarivores share many characteristics with megachiropteran nectarivores and frugivores, but differ in having a long, narrow head. Megachiropterans have wide zygomata, which would allow for more jaw musculature. Diminutive cheekteeth are characteristic of nectarivory in both suborders, but both have relatively large canines. Teeth in nectarivores can occupy as little as a tenth of the palatal area compared to nearly two-thirds in microchiropteran animalivores. The proportion that the dilambdodont stylar shelf occupies of molars in microchiropteran nectarivores can be as much as that in microchiropteran animalivores (insectivorous and carnivorous bats) or as little as that in microchiropteran frugivores but not as extreme as either. In addition to dimunitive teeth, nectarivores have fused mandibles and upper canines that are worn from contact with the lower canines (thegosis). These characteristics may be necessary for the lower jaw to support an elongated, mobile tongue. While microchiropteran nectarivory, frugivory, and carnivory probably evolved independently from an insectivorous microchiropteran ancestor, megachiropteran nectarivory probably evolved from megachiropteran frugivory or the reverse.
- Published
- 1995
- Full Text
- View/download PDF
48. Preventing Complications from High-Dose Rate Brachytherapy when Treating Mobile Tongue Cancer via the Application of a Modular Lead-Lined Spacer
- Author
-
Rinus G. Verdonschot, Souhei Furukawa, Naoya Kakimoto, Masateru Fujiwara, Shumei Murakami, Kazuhiko Ogawa, and Iori Sumida
- Subjects
Bacterial Diseases ,medicine.medical_treatment ,Brachytherapy ,Cancer Treatment ,lcsh:Medicine ,Mandible ,030218 nuclear medicine & medical imaging ,0302 clinical medicine ,Medicine and Health Sciences ,lcsh:Science ,Connective Tissue Diseases ,Lead (electronics) ,Lead (Element) ,Multidisciplinary ,Physics ,Radiotherapy Dosage ,Osteomyelitis ,Radiation Exposure ,High-Dose Rate Brachytherapy ,Tongue Neoplasms ,Chemistry ,Infectious Diseases ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,Physical Sciences ,Anatomy ,Monte Carlo Method ,Mobile tongue ,Research Article ,Chemical Elements ,Clinical Oncology ,medicine.medical_specialty ,Biophysics ,Radiation Therapy ,Carcinomas ,03 medical and health sciences ,Radiation Protection ,Tongue ,Rheumatology ,Dosimetry ,medicine ,Humans ,Mandibular Diseases ,Radiation Injuries ,Radiometry ,Mouth ,business.industry ,Radiotherapy Planning, Computer-Assisted ,lcsh:R ,Reproducibility of Results ,Biology and Life Sciences ,Cancers and Neoplasms ,Cancer ,Modular design ,medicine.disease ,Surgery ,Radiation therapy ,Lead ,Osteoradionecrosis ,lcsh:Q ,Clinical Medicine ,Tomography, X-Ray Computed ,business ,Digestive System - Abstract
PURPOSE:To point out the advantages and drawbacks of high-dose rate brachytherapy in the treatment of mobile tongue cancer and indicate the clinical importance of modular lead-lined spacers when applying this technique to patients. METHODS:First, all basic steps to construct the modular spacer are shown. Second, we simulate and evaluate the dose rate reduction for a wide range of spacer configurations. RESULTS:With increasing distance to the source absorbed doses dropped considerably. Significantly more shielding was obtained when lead was added to the spacer and this effect was most pronounced on shorter (i.e. more clinically relevant) distances to the source. CONCLUSIONS:The modular spacer represents an important addition to the planning and treatment stages of mobile tongue cancer using HDR-ISBT.
- Published
- 2016
- Full Text
- View/download PDF
49. PO-0964: High-dose-rate interstitial brachytherapy as monotherapy for locally limited mobile tongue cancer
- Author
-
H. Akiyama, Tadayuki Kotsuma, T. Shimbo, Yoshifumi Narumi, Ken Yoshida, N. Yoshikawa, Eiichi Tanaka, H. Yoshioka, Tadashi Takenaka, Koji Masui, Yasuo Uesugi, and Hideya Yamazaki
- Subjects
medicine.medical_specialty ,business.industry ,Interstitial brachytherapy ,Cancer ,Hematology ,medicine.disease ,Oncology ,Radiology Nuclear Medicine and imaging ,medicine ,Radiology, Nuclear Medicine and imaging ,Radiology ,Dose rate ,business ,Mobile tongue - Published
- 2016
- Full Text
- View/download PDF
50. Visualization of the sentinel node in early-stage oral cancer: limited value of late static lymphoscintigraphy
- Author
-
S. van Weert, C.R. Leemans, Elisabeth Bloemena, Derrek A. Heuveling, R. de Bree, K.H. Karagozoglu, Géke B. Flach, A. van Schie, MKA Vumc (OII, ACTA), Maxillofacial Surgery (VUmc), Otolaryngology / Head & Neck Surgery, Radiology and nuclear medicine, Oral and Maxillofacial Surgery / Oral Pathology, Pathology, and CCA - Innovative therapy
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pathology ,Oral cavity ,Injections ,Text mining ,SDG 3 - Good Health and Well-being ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Clinical significance ,Aged ,Neoplasm Staging ,Retrospective Studies ,Aged, 80 and over ,business.industry ,General Medicine ,Middle Aged ,Sentinel node ,Lymphatic Metastasis ,Clinical value ,Female ,Mouth Neoplasms ,Radiology ,business ,Mobile tongue ,Lymphoscintigraphy - Abstract
Objective: Various lymphoscintigraphic imaging protocols exist for sentinel node (SN) identification in early-stage oral cancer. This study aimed to evaluate the clinical value of performing additional late lymphoscintigraphic imaging. Methods: We retrospectively analysed early (directly following injection of 99mTc-Nanocoll) and late (2-4 h after injection) imaging results of 60 early-stage (T1-T2, cN0) oral cancer patients scheduled for SN procedure. Lymphoscintigraphic results of late imaging were categorized into: (a) no visualization of additional hotspots considered to be SNs; (b) additional hotspots visualized that are considered to be SNs and (c) hotspots visualized only during late imaging. Histopathological results of the harvested SNs were related to the corresponding hotspot. Results: In all patients (n=60) lymphoscintigraphy was able to visualize a hotspot that was identified as an SN. In 51/60 (85%) patients, early imaging was able to visualize at least one hotspot, whereas in 9/60 (15%) patients, mostly with oral cavity tumours other than mobile tongue and floor-of-mouth tumours, only late imaging was able to visualize hotspots. In 14/51 (27%) patients, late imaging resulted in additionally visualized hotspots marked as SNs, resulting in a more extensive surgical procedure. These additionally removed SNs appeared to be of no clinical relevance, as all SNs identified during early imaging correctly predicted whether the neck was positive or negative for cancer.Conclusion: Results of this study indicate that additional late lymphoscintigraphic imaging should be performed only in selected cases.
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.